Lung Immune Prognostic Index (LIPI)

Lung Immune Prognostic Index (LIPI) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.

Open the Lung Immune Prognostic Index (LIPI) → Runs in your browser. No signup, no tracking.

What this is

Lung Immune Prognostic Index (LIPI) is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. Lung Immune Prognostic Index (LIPI) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.

When to use it

Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.

References

Mezquita L, Auclin E, Ferrara R, et al. Association of the Lung Immune Prognostic Index with immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancer. JAMA Oncol. 2018;4(3):351-357. Read the source ↗

Worked example: Lung Immune Prognostic Index 2 — poor prognostic group.

Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.

Built by Clay Good. Source on GitHub.